Clorox (CLX) Misses Q2 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $99.16 +5.71%
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q2 EPS of $1.39, $0.05 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.
GUIDANCE:
Clorox sees FY2026 EPS of $5.95-$6.30, versus the consensus of $5.95.
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Host Hotels & Resorts (HST) Tops Q3 EPS by 1c; offers guidance
- Miller Industries (MLR) Misses Q3 EPS by 11c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
